MF

Mangala Fadnavs

Active Director Director DIN 08961572
DIN 08961572 First appointment Nov 2020 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Mangala Fadnavs

Data last updated:

Mangala Fadnavs is a Director at Equitas Pharmaceuticals Limited (since 2020). The company operates in Chemicals.

DIN 08961572
Primary Designation Director
Industry Chemicals
First Appointment 13 Nov 2020
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Equitas Pharmaceuticals Limited U24299MH2020PLC350156
Director13 Nov 20202020Active

Directorship timeline

Open interactive timeline →
Equitas Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Mangala Fadnavs

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mangala Fadnavs

Mangala Fadnavs currently holds 1 directorship: Equitas Pharmaceuticals Limited (Director, since 13 Nov 2020).

Mangala Fadnavs was first appointed on 13 Nov 2020 as Director at Equitas Pharmaceuticals Limited.

The current boards of Mangala Fadnavs's companies include Ashutosh Shyamrao Sarve (Equitas Pharmaceuticals Limited), Girish Damodar Kalamkar (Equitas Pharmaceuticals Limited), Mayuresh Dilip Katyayan (Equitas Pharmaceuticals Limited), Rahul Bhagwan Trivedi (Equitas Pharmaceuticals Limited), Saurabh Arvind Deoghare (Equitas Pharmaceuticals Limited), Yogesh Hemraj Patil (Equitas Pharmaceuticals Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available